FDA OKs Glaxo's inhaler, first one to combine 3 medicines
TRENTON, N.J. (AP) — The Food and Drug Administration has approved the first inhaler combining three medicines to ease breathing in patients with emphysema or chronic bronchitis.
The FDA late Monday approved sales of Trelegy Ellipta, developed jointly by GlaxoSmithKline PLC and Innoviva Inc. It contains three widely used types of medicine to prevent — rather than treat —flare-ups of the life-threatening breathing disorders.
Once daily, patients inhale the medicines through their mouth to open breathing passages and reduce inflammation that can make breathing difficult in people with chronic... read more
- 10:50 NFL power rankings: Getting in the Christmas spirit entering Week 15
- 10:35 Tom Brady: 'I've pretty much moved past' ugly loss to Dolphins
- 10:34 A Georgia mother battles opioids to win back her kids
- 10:34 Opioid crisis strains foster system as kids pried from homes
- 10:31 Herm Edwards' contract: 5 things to know about ASU head football...
- 10:24 4 of Arizona's tax credits could help you save thousands of dollars
- 10:24 Gilbert charter school fires teacher accused of sexual misconduct...
- 10:02 Former Arizona high school basketball players on college basketball...
- 09:57 Tom Brady: Patriots focused on putting ugly loss behind them fast
- 09:14 CEO Mary Barra: GM committed to 'harassment-free' workplace